10 Best Small Cap AI Stocks to Buy According to Analysts
On July 14, Wedbush's Dan Ives appeared on CNBC to discuss the expected tech sector earnings and explained how he thinks AI will give a boost to more than just the hyperscalers.
Recursion Pharmaceuticals Inc. (RXRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 34,815,502 | $184,174,004 | +8% | 1.84% |
| 2. | MIC Capital Partners Mubadala Investment | 9,644,032 | $51,016,935 | -1% | 10.39% |
| 3. | Citadel Investment Group Ken Griffin | 2,655,711 | $14,048,711 | -4% | 0% |
| 4. | Laurion Capital Management Benjamin A. Smith | 1,547,407 | $8,185,783 | -38% | 0.21% |
| 5. | 1,359,885 | $7,193,792 | +4% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.82 | 66,822 | $522,354.26 | 12,985,927 | 2023-03-02 | Filing | |
| $7.94 | 48,867 | $388,082.17 | 12,919,105 | 2023-03-01 | Filing | |
| $7.97 | 815 | $6,495.55 | 12,870,238 | 2023-02-28 | Filing | |
| $7.69 | 52,500 | $403,725.00 | 12,869,423 | 2023-02-27 | Filing | |
| $7.64 | 109,118 | $833,552.40 | 12,816,923 | 2023-02-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.04 | 138,574 | $836,986.96 | 1,117,450 | 2025-03-27 | Filing | |
| $6.37 | 20,000 | $127,400.00 | 1,256,024 | 2025-03-06 | Filing | |
| $6.58 | 20,000 | $131,600.00 | 1,256,024 | 2025-03-05 | Filing | |
| $8.12 | 20,000 | $162,400.00 | 1,273,156 | 2025-02-06 | Filing | |
| $7.68 | 20,000 | $153,600.00 | 1,273,156 | 2025-02-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 89,500 | $452,870 | 0.02% | |
| 2. | 38,000 | $192,280 | 0.1% | |
| 3. | 29,132 | $147,408 | 0.01% | |
| 4. | 20,943 | $117,071 | 0% | |
| 5. | 14,202 | $71,861 | 0% |
News See All
Morgan Stanley Assumes Coverage of Recursion Pharmaceuticals (RXRX) Stock with an Equal Weight Rating
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.
Recursion Pharmaceuticals (RXRX) Rallies 8.7% on Hypophosphatasia
Recursion Pharmaceuticals bounced back by 8.72 percent on Tuesday to close at $5.36 apiece following news that it acquired a $25-million interest in REV102—an ENPP1 inhibitor in preclinical development...
11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds
As per the US Bank, the healthcare in the US exhibits a large and intricate ecosystem, which is characterized by size, complexity, and influence on the broader national economy.
Recursion Pharmaceuticals (RXRX) Drops on Profit-Taking
According to Recursion Pharmaceuticals, Inc.
MIT & Recursion Unveil Boltz-2, Accelerates Drug Discovery 1000x, Rivals Physics-Based Accuracy
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks to buy according to hedge funds.
11 Best AI Stocks to Buy According to Hedge Funds
Keith Lerner, co-chief investment officer at Truist Wealth, joined CNBC's "Closing Bell" on June 27 to discuss how the bull market's dominant theme is AI.
Morgan Stanley Trims Recursion (RXRX) Price Target, Maintains Equal Weight Rating
Morgan Stanley has lowered its price target on Recursion Pharmaceuticals (NASDAQ:RXRX) to $5 from $8, while maintaining an Equal Weight rating on the stock.
10 AI Stocks That Will Skyrocket
In a bold move that highlights just how transformative artificial intelligence is becoming, Amazon CEO Andy Jassy recently warned employees that the company’s growing reliance on AI will likely lead...
Recursion Pharmaceuticals (RXRX) Jumps 31% On Next-Gen AI
We recently published a list of 15 Stocks That Stole The Show Last Week.
Billionaire Hedge Funds
